Data suggest that oral formulations of leuprolide developed utilizing Enteris’ Peptelligence® platform successfully deliver meaningful circulating drug concentrations…
SHENZHEN, China, June 13, 2022 /PRNewswire/ — Today, META Pharmaceuticals, China’s first immunometabolism-based small-molecule drug discovery company, announced…